TY - JOUR
T1 - Effect of frying-meat emission particulate on 17β-estradiol 2- and 4-hydroxylation in human lung adenocarcinoma CL5 cells
AU - Wang, Hui Wu
AU - Ueng, Tzuu-Huei
AU - Chen, Ta-Liang
AU - Yang, Pan Chyr
PY - 2003/6/27
Y1 - 2003/6/27
N2 - The effect of airborne frying-meat emission particulate (FMEP) on metabolism of 17β-estradiol (E2) to potentially toxic catechol estrogens 2- and 4-hydroxyestradiol (2- and 4-OH-E2) was determined using human lung adenocarcinoma CL5 cells treated with organic extracts of beef FMEP. E2 was incubated with microsomes prepared from untreated CL5 cells or cells treated with 200 μg/ml FMEP extract for 6 h. E2 metabolites formed were analyzed by high-performance liquid chromatography (HPLC). The results revealed that treatment with FMEP produced three-and twofold increases of 2- and 4-hydroxylation of E2, respectively. Monooxygenase activity and immunoblot analyses showed that FMEP markedly induced microsomal 7-ethoxyresorufin O-deethylase (EROD) activity and cytochrome P-450 (CYP) IAI and CYPIBI protein levels. Similar increases in E2 hydroxylation, EROD activity, and CYP protein levels were observed with HepG2 human hepatoma and MCF-7 human breast cancer cells treated with FMEP or 1 μM dibenz[a,h]anthracene. Cotreatment of CL5 cells with FMEP extract and 2 μM α-naphthoflavone, an arylhydrocarbon receptor antagonist, blocked the inductive effects of FMEP on E2 hydroxylation and EROD activity. Additions of 0.01, 0.1, or 1 μM α-naphthoflavone, a CYP inhibitor, to microsomes produced concentration-dependent decreases in E2 2-hydroxylation and EROD activity of CL5 cells induced by dibenz[a,h]anthracene. The present finding demonstrates that FMEP can increase formation of 2-OH-E2 and 4-OH-E2 by human lung cells, and induction of CYP1A1 and CYP1B1 is a potential mechanism underlying increased E2 metabolism. The toxicological significance of FMEP and estrogen interaction warrants further investigation.
AB - The effect of airborne frying-meat emission particulate (FMEP) on metabolism of 17β-estradiol (E2) to potentially toxic catechol estrogens 2- and 4-hydroxyestradiol (2- and 4-OH-E2) was determined using human lung adenocarcinoma CL5 cells treated with organic extracts of beef FMEP. E2 was incubated with microsomes prepared from untreated CL5 cells or cells treated with 200 μg/ml FMEP extract for 6 h. E2 metabolites formed were analyzed by high-performance liquid chromatography (HPLC). The results revealed that treatment with FMEP produced three-and twofold increases of 2- and 4-hydroxylation of E2, respectively. Monooxygenase activity and immunoblot analyses showed that FMEP markedly induced microsomal 7-ethoxyresorufin O-deethylase (EROD) activity and cytochrome P-450 (CYP) IAI and CYPIBI protein levels. Similar increases in E2 hydroxylation, EROD activity, and CYP protein levels were observed with HepG2 human hepatoma and MCF-7 human breast cancer cells treated with FMEP or 1 μM dibenz[a,h]anthracene. Cotreatment of CL5 cells with FMEP extract and 2 μM α-naphthoflavone, an arylhydrocarbon receptor antagonist, blocked the inductive effects of FMEP on E2 hydroxylation and EROD activity. Additions of 0.01, 0.1, or 1 μM α-naphthoflavone, a CYP inhibitor, to microsomes produced concentration-dependent decreases in E2 2-hydroxylation and EROD activity of CL5 cells induced by dibenz[a,h]anthracene. The present finding demonstrates that FMEP can increase formation of 2-OH-E2 and 4-OH-E2 by human lung cells, and induction of CYP1A1 and CYP1B1 is a potential mechanism underlying increased E2 metabolism. The toxicological significance of FMEP and estrogen interaction warrants further investigation.
UR - http://www.scopus.com/inward/record.url?scp=0038824692&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038824692&partnerID=8YFLogxK
U2 - 10.1080/15287390306361
DO - 10.1080/15287390306361
M3 - Article
C2 - 12791542
AN - SCOPUS:0038824692
SN - 1528-7394
VL - 66
SP - 1175
EP - 1188
JO - Journal of Toxicology and Environmental Health - Part A
JF - Journal of Toxicology and Environmental Health - Part A
IS - 12
ER -
